A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...
It's *** lesser known breast cancer that develops in *** patient's milk producing glands, and cases of lobular breast cancer are on the rise in the US. Most people aren't familiar with this subtype, ...
EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results